Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 20.00
+0.10 (0.50%)
At close: Apr 1, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 115.35 million as of April 1, 2026. Its market cap has increased by 3.02% in one year.
Market Cap
115.35M
Enterprise Value
262.86M
Revenue
839.38K
Ranking
n/a
PE Ratio
4.40
Stock Price
20.00
Market Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 115.35M, a decrease of -52.03%. That is a compound annual growth rate of -16.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 115.35M | -19.03% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 872.73M |
| Basilea Pharmaceutica AG | 668.66M |
| Newron Pharmaceuticals | 315.24M |
| Santhera Pharmaceuticals Holding AG | 213.08M |
| BioVersys AG | 169.59M |
| Molecular Partners AG | 116.72M |
| EvoNext Holdings | 5.91M |
| Addex Therapeutics | 5.13M |